TIM3+<i> TRBV11-2</i> T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-CLevi Hoste, Goele Nys, Stijn Vanhee et al.|The Journal of Experimental Medicine|2021Cited by 86
National real-life impact of prevention with nirsevimab on infants’ RSV hospitalizations in BelgiumSophie Blumental, Marc Raes, Adrien Lajot et al.|BMC Infectious Diseases|2026Cited by 0